EVEROLIMUS-19-ENE OPEN RING
UNII QAQ4Q483BA

Substance Identification & Data

This profile provides standardized clinical and technical data for Everolimus-19-ene Open Ring, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QAQ4Q483BA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1062122-63-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QAQ4Q483BA

CAS Registry Number

1062122-63-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EVEROLIMUS-19-ENE OPEN RING

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C53H83NO14

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PRSJHEVLVQFMHJ-FRLQEACCSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

139025362

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(=O)N1[C@H](C(O)=O)CCCC1)(=O)[C@]2(O)O[C@H](C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C([C@@H]([C@@H](/C(=C/[C@H](C(/C=C/[C@@H](C[C@H]3C[C@@H](OC)[C@H](OCCO)CC3)C)=O)C)/C)O)OC)=O)C)C)/C)OC)CC[C@H]2C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Everolimus-19-ene Open Ring. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

EVEROLIMUS EP IMPURITY B (ACID)

EVEROLIMUS-19-ENE OPEN RING

Systematic Nomenclature

(S)-1-(2-((2R,3R,6S)-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-(2-HYDROXYETHOXY)-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXODOCOSA-3,5,7,15,19-PENTAEN-1-YL)-3-METHYLTETRAHYDRO-2H-PYRAN-2-YL)-2-OXOACETYL)PIPERIDINE-2-CARBOXYLIC ACID

SYS

2-PIPERIDINECARBOXYLIC ACID, 1-(2-OXO-2-((2R,3R,6S)-TETRAHYDRO-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-(2-HYDROXYETHOXY)-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXO-3,5,7,15,19-DOCOSAPENTAEN-1-YL)-3-METHYL-2H-PYRAN-2-YL)ACETYL)-, (2S)-

SYS

External Clinical & Regulatory Resources

Previous UNIIQAQ22BKB55

Next UNIIQAQ8F7QK82